ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524715 announcements Sun Pharma. announcements and dividends declared BSE

Sun Pharma. Complete list of announcements declared & dividend announcements by Sun Pharma. 524715

Sun Pharma. 524715 listed on BSE and deals in

Announcements and dividends declared by Sun Pharma. 524715

US FDA issues 'Official Action Indicated' status to Sun Pharma’s Baska facility after inspection
Sun Pharmaceutical Industries Ltd announced that its Baska manufacturing facility has been classified as Official Action Indicated (OAI) by the US FDA following a recent inspection. Despite this classification, the company confirmed that supplies to the US
Announcement as on 18 December 2025

Delhi HC allows Sun Pharma to manufacture, export its own weight loss drug
The Delhi High Court has allowed Sun Pharma to manufacture and export its version of semaglutide, the diabetes and anti-obesity drug made by Novo Nordisk as Wegovy. However, the court barred Sun from selling the drug in India until March 2026, when Novo No
Announcement as on 10 December 2025

Sun Pharma unit to invest Rs 3,000 cr on new plant in Madhya Pradesh
Sun Pharmaceutical Industries' subsidiary, Sun Pharma Laboratories Ltd, has approved a Rs 3,000 crore investment for a new greenfield formulations manufacturing facility in Madhya Pradesh. This significant expansion by the Mumbai-based drug major aims to b
Announcement as on 03 December 2025

Sun Pharma Advanced Research jumps 11%, extends 2-day rally as US court clears Sezaby PRV
Sun Pharma Advanced Research Company surged for a second straight session after a U.S. court ruled in its favour on the Sezaby Priority Review Voucher. The stock jumped over 11%, extending Tuesday’s 20% rally, even as analysts caution about overbought tech
Announcement as on 03 December 2025

Sun Pharma brings global psoriasis drug ILUMYA to Indian market
Sun Pharmaceutical Industries has launched its innovative biologic drug, ILUMYA, in India for moderate-to-severe plaque psoriasis. This novel treatment, Tildrakizumab, has a proven track record globally for providing significant and sustained skin clearanc
Announcement as on 01 December 2025

Announcements by Sun Pharma. first page | Next page | Prev page |

524715 Sun Pharma. current price & indicator signals

Moving Averages for Sun Pharma.

  • 5Day Average: 1868.14
  • 12Day Average: 1835.87
  • 20Day Average: 1816.19
  • 50Day Average: 1805.16
  • 100Day Average: 1769.2
  • 150Day Average: 1760.49
  • 200Day Average: 1734.3

524715 Indicators & signals

Indicator MACD (12,26,9)

1844, 1828.1, 8.9
Indicator MACD is in positive zone

Indicator ADX (14)

41.82, 29.48, 12.1
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524715 Sun Pharma. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
29 Mon Jun 2026 1872.60 1857.40 to 1896.75 0.56% 0.33 times
25 Thu Jun 2026 1862.15 1858.45 to 1887.00 -0.67% 1.06 times
24 Wed Jun 2026 1874.70 1864.75 to 1882.00 0.37% 0.2 times
23 Tue Jun 2026 1867.80 1862.00 to 1901.70 0.23% 0.74 times
22 Mon Jun 2026 1863.45 1834.20 to 1865.40 1.43% 0.24 times
19 Fri Jun 2026 1837.15 1820.75 to 1843.15 0.72% 0.42 times
18 Thu Jun 2026 1824.00 1813.10 to 1829.65 0.22% 6.02 times
17 Wed Jun 2026 1819.95 1803.10 to 1822.85 1.07% 0.25 times
16 Tue Jun 2026 1800.65 1792.80 to 1809.85 -0.32% 0.24 times
15 Mon Jun 2026 1806.45 1798.50 to 1824.70 -0.04% 0.53 times
12 Fri Jun 2026 1807.25 1792.40 to 1814.60 0.72% 0.31 times
11 Thu Jun 2026 1794.30 1780.00 to 1804.90 0.4% 0.42 times

Videos related to: 524715 announcements Sun Pharma. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524715 announcements Sun Pharma. announcements and dividends declared BSE

 

Back to top